Steven Isakoff, MD, PhD

Massachusetts General HospitalBoston, Massachusetts - 02114 |
- CLINICAL TRIALS 3
- CONDITIONS1
- INTERVENTIONS8
- SINCE2007

ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer
November 2009 - October 2012

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
June 2007 - June 2011

Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
October 2007 - October 2010
Breast Neoplasms
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Cyclophosphamide
Temozolomide
Doxorubicin
Abt-888



